Xiaohua Xu1, Robert Balsiger1, Jean Tyrrell2, Prosper N Boyaka1, Robert Tarran2, Estelle Cormet-Boyaka3. 1. Department of Veterinary Biosciences, The Ohio State University, Columbus, OH, USA. 2. Cystic Fibrosis/Pulmonary Research and Treatment Center, University of North Carolina, Chapel Hill, NC, USA. 3. Department of Veterinary Biosciences, The Ohio State University, Columbus, OH, USA. Electronic address: boyaka.2@osu.edu.
Abstract
BACKGROUND: Cystic fibrosis transmembrane conductance regulator plays a key role in maintenance of lung fluid homeostasis. Cigarette smoke decreases CFTR expression in the lung but neither the mechanisms leading to CFTR loss, nor potential ways to prevent its loss have been identified to date. METHODS: The molecular mechanisms leading to down-regulation of CFTR by cigarette smoke were determined using pharmacologic inhibitors and silencing ribonucleic acids (RNAs). RESULTS: Using human bronchial epithelial cells, here we show that cigarette smoke induces degradation of CFTR that is attenuated by lysosomal inhibitors, but not proteasome inhibitors. Cigarette smoke can activate multiple signaling pathways in airway epithelial cells, including the MEK/Erk1/2 MAPK (MEK: mitogen-activated protein kinase/ERK kinase Erk1/2: extracellular signal-regulated kinase 1/2 MAPK: Mitogen-activated protein kinase) pathway regulating cell survival. Interestingly, pharmacological inhibition of the MEK/Erk1/2 MAPK pathway prevented the loss of plasma membrane CFTR upon cigarette smoke exposure. Similarly, decreased expression of Erk1/2 using silencing RNAs prevented the suppression of CFTR protein by cigarette smoke. Conversely, specific inhibitors of the c-Jun N-terminal kinase (JNK) or p38 MAPK pathways had no effect on CFTR decrease after cigarette smoke exposure. In addition, inhibition of the MEK/Erk1/2 MAPK pathway prevented the reduction of the airway surface liquid observed upon cigarette smoke exposure of primary human airway epithelial cells. Finally, addition of the antioxidant N-acetylcysteine inhibited activation of Erk1/2 by cigarette smoke and precluded the cigarette smoke-induced decrease of CFTR. CONCLUSIONS: These results show that the MEK/Erk1/2 MAPK pathway regulates plasma membrane CFTR in human airway cells. GENERAL SIGNIFICANCE: The MEK/Erk1/2 MAPK pathway should be considered as a target for strategies to maintain/restore CFTR expression in the lung of smokers.
BACKGROUND:Cystic fibrosis transmembrane conductance regulator plays a key role in maintenance of lung fluid homeostasis. Cigarette smoke decreases CFTR expression in the lung but neither the mechanisms leading to CFTR loss, nor potential ways to prevent its loss have been identified to date. METHODS: The molecular mechanisms leading to down-regulation of CFTR by cigarette smoke were determined using pharmacologic inhibitors and silencing ribonucleic acids (RNAs). RESULTS: Using human bronchial epithelial cells, here we show that cigarette smoke induces degradation of CFTR that is attenuated by lysosomal inhibitors, but not proteasome inhibitors. Cigarette smoke can activate multiple signaling pathways in airway epithelial cells, including the MEK/Erk1/2MAPK (MEK: mitogen-activated protein kinase/ERK kinase Erk1/2: extracellular signal-regulated kinase 1/2 MAPK: Mitogen-activated protein kinase) pathway regulating cell survival. Interestingly, pharmacological inhibition of the MEK/Erk1/2MAPK pathway prevented the loss of plasma membrane CFTR upon cigarette smoke exposure. Similarly, decreased expression of Erk1/2 using silencing RNAs prevented the suppression of CFTR protein by cigarette smoke. Conversely, specific inhibitors of the c-Jun N-terminal kinase (JNK) or p38MAPK pathways had no effect on CFTR decrease after cigarette smoke exposure. In addition, inhibition of the MEK/Erk1/2MAPK pathway prevented the reduction of the airway surface liquid observed upon cigarette smoke exposure of primary human airway epithelial cells. Finally, addition of the antioxidant N-acetylcysteine inhibited activation of Erk1/2 by cigarette smoke and precluded the cigarette smoke-induced decrease of CFTR. CONCLUSIONS: These results show that the MEK/Erk1/2MAPK pathway regulates plasma membrane CFTR in human airway cells. GENERAL SIGNIFICANCE: The MEK/Erk1/2MAPK pathway should be considered as a target for strategies to maintain/restore CFTR expression in the lung of smokers.
Authors: Caitlin R Stanton; Renee Thibodeau; Alexander Lankowski; Joseph R Shaw; Joshua W Hamilton; Bruce A Stanton Journal: Cell Physiol Biochem Date: 2006-06-20
Authors: Károly Varga; Asta Jurkuvenaite; John Wakefield; Jeong S Hong; Jennifer S Guimbellot; Charles J Venglarik; Ashutosh Niraj; Marina Mazur; Eric J Sorscher; James F Collawn; Zsuzsa Bebök Journal: J Biol Chem Date: 2004-04-01 Impact factor: 5.157
Authors: Jack Wellmerling; Rachael E Rayner; Sheng-Wei Chang; Elizabeth L Kairis; Sun Hee Kim; Amit Sharma; Prosper N Boyaka; Estelle Cormet-Boyaka Journal: FASEB J Date: 2022-05 Impact factor: 5.191
Authors: Elizabeth R Peitzman; Nathan A Zaidman; Peter J Maniak; Scott M O'Grady Journal: Am J Physiol Lung Cell Mol Physiol Date: 2015-11-13 Impact factor: 5.464
Authors: Stefanie Krick; Alexander Grabner; Nathalie Baumlin; Christopher Yanucil; Scott Helton; Astrid Grosche; Juliette Sailland; Patrick Geraghty; Liliana Viera; Derek W Russell; J Michael Wells; Xin Xu; Amit Gaggar; Jarrod Barnes; Gwendalyn D King; Michael Campos; Christian Faul; Matthias Salathe Journal: Eur Respir J Date: 2018-07-04 Impact factor: 16.671
Authors: Benjamin T Kopp; Juan Antonio Ortega-García; S Christy Sadreameli; Jack Wellmerling; Estelle Cormet-Boyaka; Rohan Thompson; Sharon McGrath-Morrow; Judith A Groner Journal: Int J Environ Res Public Health Date: 2016-10-12 Impact factor: 3.390